Diaceutics appoints Amie Mc Neice as VP of
Marketing
Belfast and London, 9 April
2024 - Diaceutics PLC (AIM:
DXRX), a leading technology and solutions
provider to the pharma and biotech industry, is pleased to announce
the appointment of Amie Mc Neice as Vice President of Marketing.
Amie previously held senior marketing and business development
roles with Almac Group, Fibrus and Kingspan Plc.
Amie brings a wealth of marketing
leadership experience to the team and will focus on delivering our
3-year marketing vision, brand positioning, messaging and
integration of marketing automation. Amie has significant
experience in working with US pharma customers.
Diaceutics is dedicated to scaling
its sales and marketing capabilities in the US and Europe through
2024.
Diaceutics continues to invest in
product development with the further expansion of its product
management team in 2024. The product management team will deliver
our product roadmap and co-ordinate our product activities across,
data, scientific and medical services, engagement solutions,
engineering and marketing.
Jillian Beggs, Chief Commercial
Officer of Diaceutics, commented:
"I am delighted to welcome Amie
to the team at Diaceutics. Our continued investment in sales and
marketing supports our mission to provide the data, technology
solutions and insights that enable our pharma and biotech customers
revolutionise the commercialisation of their products and
ultimately improve patient outcomes."
Amie Mc Neice, VP Marketing of
Diaceutics commented: "I have long admired Diaceutics and look
forward to working with the team as we expand our sales and
marketing capabilities and serve our customers' needs across the US
and Europe."
Enquiries:
|
Diaceutics PLC
|
|
|
Ryan Keeling, Chief Executive
Officer
Nick Roberts, Chief Financial
Officer
|
Tel: +44 (0)28 9040 6500
investorrelations@diaceutics.com
|
|
|
|
|
Stifel Nicolaus Europe Limited (Nomad &
Broker)
|
Tel: +44 (0)20 7710
7600
|
|
Ben Maddison, Nick Harland, Kate Hanshaw
|
|
|
|
|
|
Alma Strategic Communications
|
Tel: +44(0)20 3405
0205
|
|
Caroline Forde, Kinvara Verdon,
Kieran Breheny
|
diaceutics@almastrategic.com
|
|
|
|
About Diaceutics
At Diaceutics we believe that every
patient should get the opportunity to receive the right test and
the right therapy to positively impact their disease
outcome.
We provide the world's leading pharma
and biotech companies with an end-to-end commercialisation solution
for precision medicines through data analytics, scientific and
advisory services enabled by our platform DXRX - The Diagnostics
Network ®.